Other formats:
BibTeX
LaTeX
RIS
@article{1116739, author = {Mlčochová, Jitka and Faltejsková, Petra and Němeček, Radim and Svoboda, Marek and Slabý, Ondřej}, article_number = {10}, doi = {http://dx.doi.org/10.1007/s00432-013-1470-9}, keywords = {MicroRNA; Colorectal cancer; EGFR signalling pathway; Predictive biomarkers; Prognostic biomarkers}, language = {eng}, issn = {0171-5216}, journal = {Journal of cancer research and clinical oncology}, title = {MicroRNAs targeting EGFR signalling pathway in colorectal cancer}, url = {http://link.springer.com/article/10.1007%2Fs00432-013-1470-9}, volume = {139}, year = {2013} }
TY - JOUR ID - 1116739 AU - Mlčochová, Jitka - Faltejsková, Petra - Němeček, Radim - Svoboda, Marek - Slabý, Ondřej PY - 2013 TI - MicroRNAs targeting EGFR signalling pathway in colorectal cancer JF - Journal of cancer research and clinical oncology VL - 139 IS - 10 SP - 1615-1624 EP - 1615-1624 PB - Springer-Verlag SN - 01715216 KW - MicroRNA KW - Colorectal cancer KW - EGFR signalling pathway KW - Predictive biomarkers KW - Prognostic biomarkers UR - http://link.springer.com/article/10.1007%2Fs00432-013-1470-9 L2 - http://link.springer.com/article/10.1007%2Fs00432-013-1470-9 N2 - MicroRNAs (miRNAs) are short, 18–25- nucleotide long, non-coding single-stranded RNAs, which are capable to regulate gene expression on post-transcrip- tional level through binding to their target protein-encoding mRNAs. miRNAs regulate individual components of multiple oncogenic pathways. One of them is epidermal growth factor receptor (EGFR) signalling pathway that regulates cell proliferation, differentiation, migration, angiogenesis and apoptosis. All these processes are deregulated in colorectal cancer (CRC). Moreover, EGFR has been validated as the therapeutic target in CRC, and monoclonal antibodies cetuximab and panitumumab are used in the therapy of patients with metastatic CRC. Because of the extensive involvement of miRNAs in the regulation of EGFR signalling, it seems they could also serve as promising predictive biomarkers to anti-EGFR therapy. In this review, we summarize current knowledge about miRNAs targeting EGFR signalling pathway, their functioning in CRC pathogenesis and potential usage as biomarkers. ER -
MLČOCHOVÁ, Jitka, Petra FALTEJSKOVÁ, Radim NĚMEČEK, Marek SVOBODA and Ondřej SLABÝ. MicroRNAs targeting EGFR signalling pathway in colorectal cancer. \textit{Journal of cancer research and clinical oncology}. Springer-Verlag, 2013, vol.~139, No~10, p.~1615-1624. ISSN~0171-5216. Available from: https://dx.doi.org/10.1007/s00432-013-1470-9.
|